Simone A.P. van Luxemburg-Heijs

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Liesbeth C. de Wreede et al. · Journal of Clinical Investigation · 2017 · 99 citations · Full text

Histocompatibility, Cell Therapy, T Cell Reactivity +18

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene

Cornelis A.M. van Bergen, Michel G.D. Kester, Inge Jedema et al. · Blood · 2007 · 86 citations

High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning

Cornelis A.M. van Bergen, Caroline E. Rutten, Edith D. van der Meijden et al. · Cancer Research · 2010 · 85 citations · Full text

Histocompatibility, Hla, Immunology +23

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Sanja Stevanović, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs et al. · Blood · 2013 · 79 citations · Full text

Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity

Marieke Griffioen, Edith D. van der Meijden, Elisabeth H. Slager et al. · Proceedings of the National Academy of Sciences · 2008 · 67 citations · Full text

Histocompatibility, Cell Therapy, Hla Immunogenetics +18